Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2
内源性 PGH 合酶 2 的致突变性/基因毒性
基本信息
- 批准号:6801756
- 负责人:
- 金额:$ 2.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Prostaglandin H synthase (PGHS) plays a
significant role in inflammation and carcinogenesis. PGHS form 2 (PGHS-2)
induced by mitogens, growth factors and tumor promotors causes mutagenicity and
genotoxicity. A bacterial test is not suitable because reactive toxicants
produced by PGHS-2 are short-lived and cannot easily cross the bacterial
membrane.
Our objective is to develop colorimetric/chemiluminescent and fluorescent
real-time quantitative PCR (QPCR) assays to quantitate DNA damage mediated by
endogenous human PGHS-2. In Phase I, we expressed human PGHS-2 in human DNA
repair deficient fibroblast cell line, XPA, treated the cells with
benzo(a)pyrene-7,8-dihydrodiol and measured DNA damage by QPCR of 16.2 kb
mitochondrial DNA using colorimetric/chemiluminescent assays.
In Phase II, we will improve the colorimetric/chemiluminescent QPCR assay
internal control DNAs and develop a fluorescent real-time QPCR assay. We will
also develop QPCR assays with a DNA damage repair-proficient human fibroblast
cell line after transfection of the cells with a PGHS-2 gene-containing vector.
QPCR assays will also be developed with human PGHS-1 expressing XPA. Utilities
of the assays will be explored by treatment of the cells with several
environmental toxicants.
PROPOSED COMMERCIAL APPLICATION:
Increased expression of PGHS-2 may lead to development of human tumors including colon cancer. Reliable mutagenicity and genotoxicity assays with PGHS-2 expressed in eukaryotic cells is in great demand. Thus, facile colorimetric/ECL and fluorescent Real-Time quantitative PCR (QPCR) assays will be developed with human PGHS-2 :expressed in human DNA repair deficient and proficient fibroblasts. The QPCR assay kits will be marketed to screen PGHS-2-dependent promutagens and DNA damaging agents as well as chemopreventive agents.
描述(由申请人提供):前列腺素H合成酶(PGHS)起作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hyesook Kim其他文献
Hyesook Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hyesook Kim', 18)}}的其他基金
Glycoproteins and Glycan-Binding IgGs: Biomarkers for Cancer and Inflammatory Di
糖蛋白和聚糖结合 IgG:癌症和炎症性疾病的生物标志物
- 批准号:
8250520 - 财政年份:2012
- 资助金额:
$ 2.52万 - 项目类别:
Glycoproteins and Glycan-Binding IgGs: Biomarkers for Cancer and Inflammatory Di
糖蛋白和聚糖结合 IgG:癌症和炎症性疾病的生物标志物
- 批准号:
8535687 - 财政年份:2012
- 资助金额:
$ 2.52万 - 项目类别:
Targeted Antibody Microarrays:Tool for Toxicoproteomics
靶向抗体微阵列:毒理学蛋白质组学工具
- 批准号:
7120162 - 财政年份:2005
- 资助金额:
$ 2.52万 - 项目类别:
Targeted Antibody Microarrays:Tool for Toxicoproteomics
靶向抗体微阵列:毒理学蛋白质组学工具
- 批准号:
6938769 - 财政年份:2005
- 资助金额:
$ 2.52万 - 项目类别:
"Xenopus Microarrays: A Tool for Molecular Toxicology"
“非洲爪蟾微阵列:分子毒理学的工具”
- 批准号:
6690273 - 财政年份:2003
- 资助金额:
$ 2.52万 - 项目类别:
Fetal Alcohol Syndrome Biomarkers by Antibody Microarr
Antibody Microarr 胎儿酒精综合症生物标志物
- 批准号:
6801387 - 财政年份:2003
- 资助金额:
$ 2.52万 - 项目类别:
"Xenopus Microarrays: A Tool for Molecular Toxicology"
“非洲爪蟾微阵列:分子毒理学的工具”
- 批准号:
6799219 - 财政年份:2003
- 资助金额:
$ 2.52万 - 项目类别:
Fetal Alcohol Syndrome Biomarkers by Antibody Microarray
通过抗体微阵列检测胎儿酒精综合症生物标志物
- 批准号:
6699092 - 财政年份:2003
- 资助金额:
$ 2.52万 - 项目类别:
Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2
内源性 PGH 合酶 2 的致突变性/基因毒性
- 批准号:
6405320 - 财政年份:2001
- 资助金额:
$ 2.52万 - 项目类别:
Mutagenicity/Genotoxicity with Endogenous PGH Synthase-2
内源性 PGH 合酶 2 的致突变性/基因毒性
- 批准号:
6518251 - 财政年份:2001
- 资助金额:
$ 2.52万 - 项目类别:
相似海外基金
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
- 批准号:
10748479 - 财政年份:2024
- 资助金额:
$ 2.52万 - 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
- 批准号:
2338236 - 财政年份:2024
- 资助金额:
$ 2.52万 - 项目类别:
Continuing Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
- 批准号:
23K07078 - 财政年份:2023
- 资助金额:
$ 2.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
- 批准号:
10550045 - 财政年份:2023
- 资助金额:
$ 2.52万 - 项目类别:
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
- 批准号:
23H05475 - 财政年份:2023
- 资助金额:
$ 2.52万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
- 批准号:
2246561 - 财政年份:2023
- 资助金额:
$ 2.52万 - 项目类别:
Standard Grant
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
- 批准号:
10666307 - 财政年份:2023
- 资助金额:
$ 2.52万 - 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
- 批准号:
10651048 - 财政年份:2023
- 资助金额:
$ 2.52万 - 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
- 批准号:
10734425 - 财政年份:2023
- 资助金额:
$ 2.52万 - 项目类别:














{{item.name}}会员




